as 12-24-2024 4:00pm EST
Stocks
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
Founded: | 2006 | Country: | United States |
Employees: | N/A | City: | LAFAYETTE |
Market Cap: | 369.2M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 127.7K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.25 | EPS Growth: | 4.13 |
52 Week Low/High: | $6.21 - $10.44 | Next Earning Date: | 11-06-2024 |
Revenue: | $214,301,000 | Revenue Growth: | 26.22% |
Revenue Growth (this year): | 23.46% | Revenue Growth (next year): | 12.43% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Kaushal Nitin | VMD | Director | Nov 25 '24 | Sell | $8.64 | 30,000 | $260,280.60 | 126,843 | |
Kaushal Nitin | VMD | Director | Nov 19 '24 | Sell | $8.53 | 30,000 | $255,900.00 | 126,843 | |
Dobbs Randy E. | VMD | Director | Nov 13 '24 | Sell | $9.28 | 36,261 | $336,502.08 | 107,706 | |
Kaushal Nitin | VMD | Director | Nov 11 '24 | Sell | $9.52 | 60,000 | $571,200.00 | 126,843 |
VMD Breaking Stock News: Dive into VMD Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
Simply Wall St.
23 days ago
Simply Wall St.
a month ago
GlobeNewswire
2 months ago
Simply Wall St.
2 months ago
Simply Wall St.
2 months ago
GlobeNewswire
2 months ago
Simply Wall St.
3 months ago
The information presented on this page, "VMD Viemed Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.